Segal Trials Showcased Leadership in CNS Research and Psychedelic Studies at CNS Summit 2023
As a founding member of CNS Summit since 2010, Segal Trials continues to make a significant impact in central nervous system (CNS) research and remains at the forefront of cutting-edge psychedelic science.
- As a founding member of CNS Summit since 2010, Segal Trials continues to make a significant impact in central nervous system (CNS) research and remains at the forefront of cutting-edge psychedelic science.
- Participating in CNS Summit 2023 allows us to share our insights and contribute to the global conversation on psychedelic research."
- As one of the first private research sites to conduct psychedelic clinical studies in the US, Segal Trials continues to reinforce its position as a leading research site network.
- For more information about Segal Trials and their participation in CNS Summit 2023, please visit www.SegalTrials.com